Alphamab Oncology Market Cap

Alphamab Oncology has a market cap or net worth of 8.69 billion as of February 13, 2026. Its market cap has increased by 166.31% in one year.

Market Cap

8.69B

Enterprise Value

7.19B

Revenue

861.24M

Ranking

n/a

PE Ratio

34.65

Stock Price

8.97

Market Cap Chart

Since December 12, 2019, Alphamab Oncology's market cap has decreased from 12.11B to 8.69B, a decrease of -28.25%. That is a compound annual growth rate of -5.23%.

Market Cap History

Date	Market Cap	% Change
Feb 12, 2026	8.62B	-9.18%
Dec 31, 2025	9.49B	181.80%
Dec 31, 2024	3.37B	-47.42%
Dec 29, 2023	6.41B	-36.87%
Dec 30, 2022	10.15B	-20.36%
Dec 31, 2021	12.74B	-16.28%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 12, 2019	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Guangzhou Innogen Pharmaceutical Group	12.62B
Nanjing Leads Biolabs	12.01B
Shanghai Haohai Biological Technology	11.04B
HBM Holdings	9.79B
Abbisko Cayman	9.05B
Lepu Biopharma	8.48B
CStone Pharmaceuticals	8.25B
CK Life Sciences Int'l., (Holdings)	8.07B

Market Cap Rankings